Denmark· DK-28106308419
Caloket
A ketorolac product containing ketorolactrometamol, registered in Denmark by EQL Pharma AB. The same ATC class is registered in 9 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Ketorolac is registered in 9 of 19 countries.
Countries holding a registration under ATC M01AB15 (ketorolac), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Ketorolac · ATC M01AB15
9 / 19 countries
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ketorolac costs, country by country.
Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ketorolac · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- US United States$0.49 (acquisition cost)
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Ketorolactrometamol
- Manufacturer
- EQL Pharma AB
- Country
- Denmark (DK)
- ATC code
- M01AB15
- ATC class
- Ketorolac
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106308419
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
378 interactions on record for ketorolac.
Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ketorolac · interactions on record
378 records
- 69 severe
- 129 moderate
- 5 minor
- 94 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under M01AB15
Ketorolac, as other registers publish it.
- CanadaAPO-KETOROLACAPOTEX INC
- ItalyBENKETOLPHARMABER S.R.L.
- FinlandCaloketEQL Pharma AB
- NorwayCaloketEQL Pharma AB
- ItalyEUMATEPIFARMA S.R.L.
- CanadaJAMP KETOROLACJAMP PHARMA CORPORATION
- United KingdomKetorolac 30mg/1ml solution for injection ampoulesPeckforton Pharmaceuticals Ltd
- United KingdomKetorolac 30mg/1ml solution for injection ampoulesA A H Pharmaceuticals Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b20b5db5-68ac-4f03-bc05-df0839502106 GET /v1/drugs/b20b5db5-68ac-4f03-bc05-df0839502106?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektions-/infusionsvæske, opløsning",
"source": "dkma",
"strength": "30 mg/ml",
"auth_role": "RMS",
"dk_drugid": "28106308419",
"substance": "Ketorolactrometamol",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": false,
"registration_date_serial": "44778"
}See everything about ketorolac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.